Empowering Breast Surgeons: A Call for Collective Action
As survival rates continue to rise for patients with breast cancer, innovations are still needed to advance surgical care for these patients.
As survival rates continue to rise for patients with breast cancer, innovations are still needed to advance surgical care for these patients.
China’s CDE has granted breakthrough therapy designation to first-line sunvozertinib for EGFR exon 20 insertion mutation–positive NSCLC.
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
An abstract is unavailable.
CAR T-cell therapy demonstrated efficacy and manageable safety in mantle cell lymphoma in a systematic review of prospective and real-world studies.
The DetermaIO gene expression test was predictive of responses to neoadjuvant atezolizumab plus chemotherapy in early-stage triple-negative breast cancer.
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Fixed-duration ibrutinib plus venetoclax generated meaningful survival benefits and durable responses in high-risk subgroups of patients with CLL/SLL.
An abstract is unavailable.
ASTCT introduces the Gene Therapy Summit, an interactive meeting of representatives from academic and clinical centers, the biotechnology industry, ASTCT and additional collaborative professional societies…
A single-dose formulation of paclitaxel for injectable suspension has been launched in the United States for metastatic breast cancer.